Nomad Power Solutions NMAD
NASDAQ NMAD
$3.71 +0.00 (+0.00%)
At close: Sep 10, 2026 · 4:00 PM EDT

Nomad Power Solutions (NMAD) Common Equity (2010 - 2026)

Nomad Power Solutions (NMAD) posted Common Equity of $25.0 million for Q2 2026, up 127.96% on a QoQ basis from $11.0 million in Q4 2025, and up 3735.69% year-over-year from $651456.0 in Q2 2025.

Analysis

Nomad Power Solutions (NMAD) Common Equity (2010 - 2026) Analysis & Trends

Nomad Power Solutions has reported Common Equity for 17 years, with the latest figure at $25.0 million in Q2 2026.

  • On a quarterly basis, Common Equity rose 3735.69% year-over-year to $25.0 million in Q2 2026; TTM through Jun 2026 was $25.0 million, a 3735.69% increase from a year earlier, with the FY2025 full-year figure at $11.0 million, up 1225.11% from the prior year.
  • Common Equity was $25.0 million for Q2 2026 at Nomad Power Solutions, up from $11.0 million in the prior quarter.
  • The five-year high for Common Equity was $25.0 million in Q2 2026, with the low at $651456.0 in Q2 2025.
  • Average Common Equity over 5 years is $5.2 million, with a median of $4.0 million recorded in 2023.
  • The sharpest annual moves came in 2024 and 2026: Common Equity slumped 79.29% in 2024, then jumped 3735.69% in 2026.
  • Over 5 years, Common Equity stood at $5.2 million in 2022, then dropped by 22.66% to $4.0 million in 2023, then slumped by 79.29% to $827219.0 in 2024, then jumped by 1225.11% to $11.0 million in 2025, then jumped by 127.96% to $25.0 million in 2026.
  • The last three Common Equity figures came in at $25.0 million (Q2 2026), $11.0 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.42 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.35 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.92 Bn
10 Nomad Power Solutions 49.59 Mn 49.59 Mn - 24.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 24.99 Mn
Dec 31, 2025 10.96 Mn
Sep 30, 2025 4.91 Mn
Jun 30, 2025 651,456.00
Mar 31, 2025 1.16 Mn
Dec 31, 2024 827,219.00
Sep 30, 2024 1.37 Mn
Jun 30, 2024 2.25 Mn
Mar 31, 2024 3.13 Mn
Dec 31, 2023 3.99 Mn
Sep 30, 2023 4.92 Mn
Jun 30, 2023 2.69 Mn
Mar 31, 2023 4.08 Mn
Dec 31, 2022 5.17 Mn
Sep 30, 2022 6.41 Mn
Jun 30, 2022 7.49 Mn
Mar 31, 2022 3.47 Mn
Dec 31, 2021 4.79 Mn
Sep 30, 2021 6.07 Mn
Jun 30, 2021 6.87 Mn